All News

Roche updates oseltamivir prescribing information.

Pharmacists divided over whether Medicare should require e-prescribing.

PhRMA releases report on neurological drugs in development and Hispanics would benefit most from these products.

Louisiana hospital pharmacy under investigation

CVS opens its 500th MinuteClinic location and plans continued expansion

Two pharmacy schools in California have named new faculty to promote cultural diversity Pharmacy schools train sights on cultural diversity.

Promoting awareness of colon cancer and patient education for March and April.

Professional groups hope community pharmacy can expand provider role.

Palo Alto Labs recalls Aspire36 and Aspire Lite dietary supplements.

Washington pharmacy owner sentenced to 18 months in jail for fraud.

The International Academy of Compounding Pharmacists wants to find out when the Food & Drug Administration became interested in cracking down on the use of estriol for bio-identical hormone replacement therapy.

A nonprofit group concerned over short stature in kids opposes legislation now under consideration in Congress that would move human growth hormone into Schedule III of the Controlled Substances Act.

AMA asks patients if they know what expired medicines are in their homes.

Desvenlafaxine is approved by FDA for depression in adults.

Expanded labeling approved for sitagliptin/metformin.

Baxter Healthcare Corp. recalls remaining heparin lots.

FDA advisory on ingestion of tiotropium and formoterol capsules

Aripiprazole approved for new indication.

NACDS Foundation promotes use of a personal medication record to help patients

The pharmacy benefit manager Medco is breaking new ground in using clinical pharmacists to provide direct patient care.

New recommendations regarding diet represent a departure from the past.

To uncover drug errors, it's best to use a nonpunitive approach.

The National Foundation for Infectious Diseases has issued two reports to increase influenza immunization rates among health employees.

Liver injury warnings added to natalizumab prescribing information.

Esomeprazole approved for children.

The Centers for Disease Control & Prevention recommends influenza vaccine for all children six months to 18 years old.

Rilonacept approved as orphan drug for Cryopyrin-Associated Periodic Syndromes (CAPS).